These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1138642)

  • 1. A comparative analysis of warfarin and low-dose heparin as thromboembolism prophylaxis in total hip replacement patinets.
    Ritter MA; HamiltonCW
    Ann Surg; 1975 Jun; 181(6):896-901. PubMed ID: 1138642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement.
    Barber HM; Feil EJ; Galasko CS; Edwards DH; Sutton RA; Haynes DW; Bentley G
    Postgrad Med J; 1977 Mar; 53(617):130-3. PubMed ID: 859784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of low-dose heparin--warfarin anticoagulation prophylaxis after total hip replacement arthroplasty.
    Goss TP; Stinchfield FE; Cosgriff SW
    Clin Orthop Relat Res; 1979 Jun; (141):134-7. PubMed ID: 477094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
    J Bone Joint Surg Am; 1994 Aug; 76(8):1174-85. PubMed ID: 8056798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis.
    Salvati EA; Lachiewicz P
    J Bone Joint Surg Am; 1976 Oct; 58(7):921-5. PubMed ID: 977621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty.
    Skedgel C; Goeree R; Pleasance S; Thompson K; O'brien B; Anderson D
    J Bone Joint Surg Am; 2007 Apr; 89(4):819-28. PubMed ID: 17403806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose heparin therapy in the long-term management of venous thromboembolism.
    Bynum LJ; Wilson JE
    Am J Med; 1979 Oct; 67(4):553-6. PubMed ID: 386791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of prophylaxis in total hip replacement.
    Paiement GD; Wessinger SJ; Harris WH
    Am J Surg; 1991 Apr; 161(4):519-24. PubMed ID: 1903606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolic complications of hip fractures.
    Rogers PH; Marder VJ
    Orthop Clin North Am; 1974 Jul; 5(3):509-23. PubMed ID: 4837049
    [No Abstract]   [Full Text] [Related]  

  • 11. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures.
    Moskovitz PA; Ellenberg SS; Feffer HL; Kenmore PI; Neviaser RJ; Rubin BE; Varma VM
    J Bone Joint Surg Am; 1978 Dec; 60(8):1065-70. PubMed ID: 363722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
    Imperiale TF; Speroff T
    JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery].
    Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
    Harris WH; Salzman EW; Athanasoulis C; Waltman AC; Baum S; DeSanctis RW
    J Bone Joint Surg Am; 1974 Dec; 56(8):1552-62. PubMed ID: 4434023
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis for venous thromboembolism in total hip arthroplasty: a review.
    O'Meara PM; Kaufman EE
    Orthopedics; 1990 Feb; 13(2):173-8. PubMed ID: 1689843
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve.
    Lee PK; Wang RY; Chow JS; Cheung KL; Wong VC; Chan TK
    J Am Coll Cardiol; 1986 Jul; 8(1):221-4. PubMed ID: 3711520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty.
    White RH; Gettner S; Newman JM; Trauner KB; Romano PS
    N Engl J Med; 2000 Dec; 343(24):1758-64. PubMed ID: 11114314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of venous thromboembolism by aspirin, warfarin and heparin in patients with hip fracture. A prospective clinical study with cost-benefit analysis.
    Alho A; Stangeland L; Røttingen J; Wiig JN
    Ann Chir Gynaecol; 1984; 73(4):225-8. PubMed ID: 6439100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with low-friction arthroplasty. A statistical review of early results and complications.
    Eftekhar NS; Stinchfield FE
    Clin Orthop Relat Res; 1973 Sep; (95):60-8. PubMed ID: 4754219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.